
    
      Protocol Objectives include:

        -  Determine the proportion of patients with HCC in whom the treatment plan can be
           completed

        -  Evaluate the response to therapy

        -  Evaluate toxicities and adverse experiences associated with TheraSphere treatment

        -  Evaluate survival time
    
  